Sage Journals: Discover world-class research

Open access

Research article

First published 2025

Sex differences in relapse-independent and relapse-associated disability progression in relapsing-remitting multiple sclerosis: a real-world inverse-probability weighted study

Matteo Foschi, Damiano Marastoni, Ivan Panzera [...]

Therapeutic Advances in Neurological Disorders

Retricted access

Research article

First published 2024-10

The time to include cognition in the multiple sclerosis concept of progression independent from relapse activity is now

Stefano Ziccardi, Maddalena Guandalini, Tom A Fuchs [...]

Multiple Sclerosis Journal

Retricted access

Research article

First published 2024-4

Paramagnetic rim lesions predict greater long-term relapse rates and clinical progression over 10 years

Jack A Reeves, Maryam Mohebbi, Taylor Wicks [...]

Multiple Sclerosis Journal

Retricted access

Research article

First published 2015-6

Fingolimod effect on brain volume loss independently contributes to its effect on disability

MP Sormani, N De Stefano, G Francis [...]

Multiple Sclerosis Journal

Open access

Review article

First published 2025

Aggressive treatment of early acute focal inflammatory activity to extend the window for BTK inhibition in multiple sclerosis

Joost Smolders, Ide Smets, Beatrijs Wokke

Therapeutic Advances in Neurological Disorders

Open access

Research article

First published 2023-8

Glial fibrillary acidic protein and multiple sclerosis progression independent of acute inflammation

Xiaotong Jiang, Changyu Shen, Charlotte E Teunissen [...]

Multiple Sclerosis Journal

Open access

Research article

First published 2025

Prognostic value of blood-based biomarkers in multiple sclerosis patients in the absence of clinical relapses or new MRI lesions

Tobias Brummer, Gabriel Gonzalez-Escamilla, Falk Steffen [...]

Therapeutic Advances in Neurological Disorders

Retricted access

Research article

First published 2022-9

Olfactory threshold predicts treatment response in relapsing multiple sclerosis

Gabriel Bsteh, Harald Hegen, Klaus Berek [...]

Multiple Sclerosis Journal

Open access

Review article

First published 2022

Smouldering multiple sclerosis: the ‘real MS’

Gavin Giovannoni, Veronica Popescu, Jens Wuerfel [...]

Therapeutic Advances in Neurological Disorders

Open access

Research article

First published 2022

Comparative effectiveness of natalizumab versus ocrelizumab in multiple sclerosis: a real-world propensity score–matched study

Katrin Pape, Leoni Rolfes, Falk Steffen [...]

Therapeutic Advances in Neurological Disorders

Search results